Published 2016
| Version v1
Publication
Pathophysiological studies are mandatory to understand the benefit of proton pump inhibitors in patients with idiopathic pulmonary fibrosis
Contributors
Additional details
Identifiers
- URL
- http://hdl.handle.net/11567/871628
- URN
- urn:oai:iris.unige.it:11567/871628
Origin repository
- Origin repository
- UNIGE